Synmosa Biopharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	15,796	14,499	14,706	16,021	7,016	6,814
Market Cap Growth	9.59%	-1.41%	-8.21%	128.36%	2.96%	20.87%
Enterprise Value	17,696	16,554	17,100	19,459	10,892	11,385
Last Close Price	31.50	30.68	30.79	34.75	15.05	14.33
PE Ratio	19.95	21.18	24.72	20.05	23.09	10.68
Forward PE	-	28.41	28.41	28.41	28.41	28.41
PS Ratio	2.59	2.61	2.86	3.65	2.17	2.24
PB Ratio	1.59	1.73	1.82	2.41	1.15	1.14
P/TBV Ratio	1.93	2.16	2.39	3.38	1.67	1.73
P/FCF Ratio	67.28	25.61	48.24	31.98	19.39	68.14
P/OCF Ratio	33.36	18.57	28.73	25.42	15.42	26.79
EV/Sales Ratio	2.90	2.98	3.33	4.44	3.37	3.75
EV/EBITDA Ratio	16.12	15.38	18.43	25.58	22.83	25.99
EV/EBIT Ratio	23.15	22.34	27.72	42.24	58.33	76.15
EV/FCF Ratio	75.37	29.24	56.09	38.84	30.10	113.85
Debt / Equity Ratio	0.28	0.30	0.30	0.51	0.57	0.62
Debt / EBITDA Ratio	2.50	2.37	2.56	4.32	7.15	8.30
Debt / FCF Ratio	11.96	4.50	7.98	6.70	9.57	37.02
Net Debt / Equity Ratio	0.06	0.08	0.10	0.29	0.41	0.50
Net Debt / EBITDA Ratio	0.54	0.62	0.84	2.55	5.19	6.75
Net Debt / FCF Ratio	2.58	1.18	2.57	3.87	6.84	29.56
Asset Turnover	0.47	0.46	0.45	0.41	0.31	0.32
Inventory Turnover	1.75	1.83	1.99	1.97	1.59	1.74
Quick Ratio	1.52	1.54	1.35	1.10	0.95	0.94
Current Ratio	2.45	2.42	2.14	1.73	1.64	1.91
Return on Equity (ROE)	6.03%	5.68%	5.49%	9.71%	1.93%	8.82%
Return on Assets (ROA)	3.76%	3.85%	3.36%	2.68%	1.13%	0.98%
Return on Invested Capital (ROIC)	5.95%	5.87%	4.76%	4.58%	1.61%	1.74%
Return on Capital Employed (ROCE)	6.80%	7.20%	6.40%	5.20%	2.20%	1.70%
Earnings Yield	4.87%	4.72%	4.04%	4.99%	4.33%	9.37%
FCF Yield	1.49%	3.91%	2.07%	3.13%	5.16%	1.47%
Dividend Yield	1.76%	1.78%	1.61%	1.31%	2.31%	1.28%
Payout Ratio	35.41%	33.41%	32.69%	18.60%	26.32%	7.16%
Buyback Yield / Dilution	-5.14%	-3.52%	-3.84%	0.79%	-2.35%	-9.76%
Total Shareholder Return	-3.38%	-1.74%	-2.22%	2.10%	-0.04%	-8.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.